1. Atractylenolides (I, II, and III): a review of their pharmacology and pharmacokinetics

   • Mao Deng
   • Huijuan Chen
   • Xiaofang Li

   Review 16 July 2021 Pages: 633 - 654

   

2. Aldose Reductase: a cause and a potential target for the treatment of diabetic complications

   • Sapna Thakur
   • Sonu Kumar Gupta
   • Malkhey Verma

   Review 19 July 2021 Pages: 655 - 667

   

3. Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson’s disease

   • Eun-Joo Shin
   • Ji Hoon Jeong
   • Hyoung-Chun Kim

   Review 20 July 2021 Pages: 668 - 688

   

4. Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120

   • Young-Jung Lee
   • In Jun Yeo
   • Jin Tae Hong

   Research Article Open access 23 July 2021 Pages: 689 - 701

   

5. Ginsenoside-Rg2 exerts anti-cancer effects through ROS-mediated AMPK activation associated mitochondrial damage and oxidation in MCF-7 cells

   • Hyesu Jeon
   • Yujin Jin
   • Kyung-Sun Heo

   Research Article 24 July 2021 Pages: 702 - 712

   

6. Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism

   • Young-Hoon Kim
   • Pureum Kang
   • Seok-Yong Lee

   Research Article 25 July 2021 Pages: 713 - 724

   

7. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis

   • Sujata Purja
   • Hocheol Shin
   • EunYoung Kim

   Research Article 24 July 2021 Pages: 725 - 740